Yuli Qian
9PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Nov 20, 2025
Optimization of Bottom-Up PBPK Model Development in SIMCYP via Retrospective Analysis of Clinical Human PK Data.Julia A Schulz Pauly, Alix F Leblanc, Ekram A Chowdhury
|Aug 05, 2025
Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib Development.Sumit Bhatnagar, Sven Stodtmann, Yuli Qian
|Dec 17, 2024
Endogenous plasma riboflavin is not a viable BCRP biomarker in human.John P Savaryn, Ryota Kikuchi, Yuli Qian
|Nov 14, 2024
Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular-Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open-Label, Phase 1 Trial.Hermine I Brunner, Anna Shmagel, Gerd Horneff
|Sep 30, 2024
Extrapolation of Upadacitinib Efficacy in Juvenile Idiopathic Arthritis Leveraging Pharmacokinetics, Exposure-Response Models, and Real-World Patient Data.Yuli Qian, Louisa Schlachter, Doerthe Eckert
|Aug 05, 2024
Coproporphyrin-I as a Selective OATP1B Biomarker Can Be Used to Delineate the Mechanisms of Complex Drug-Drug Interactions: Cedirogant Case Study.Ryota Kikuchi, Yuli Qian, Mohamed Badawi
Pageof 2
Frequent Collaborators
6 joint publications
Mohamed-Eslam F Mohamed
4 joint publications
Wei Liu
3 joint publications
Ryota Kikuchi
2 joint publications
Anna Shmagel
2 joint publications
Sven Stodtmann
1 joint publications
Ronilda D'Cunha
1 joint publications
Mohamed Badawi
1 joint publications
John P Savaryn
1 joint publications
Shashikanth Gannu
1 joint publications
Shuai Hao
